I know you disagree but if you get a chance to read the June 2, 2014 press release it will answer some of your questions if you choose to beleive it. Concerning the FDA...CBIS is doing research and patient trials in Europe and South America...why? The FDA drug approval process is long as you know. The products, if proven to be successfull will be produced in the countries that CBIS's PHD Research Teams are testing the cannabis products in. When the results are documented in Medical Journels and has support from peer reviews and approved, the FDA is more likely to approve the products in the United States. Part of the complication is the laws are changing but not in all States concerning MMJ or with the Federal Goverment so far. When all these ducks are lined up CBIS will be the company in the forefront of Medical Marijuana, far ahead of any competition. This is my opinion which I understand is different from yours or some others which is OK. CBIS is worth the wait for me. Everyone has choices my choice is to support CBIS, their Management Team, and their PHD Research and Development Teams. The work they do and the products they develope will help thousands of people with serious illnesses. I happy to be part of this.
